Crisis Report Calls for Urgent Actions, Offers Roadmap on AMR for Japan and Other Aging Societies

The coupled crises of rising rates of drug resistant infections and stagnating antibiotic innovation is especially perilous for Japan and other aging societies, says new report from the Global Coalition on Aging and Health and Global Policy Institute, released during Japan’s AMR Awareness Month.

Tokyo, JAPAN (November 18, 2021) – A new report released today by the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) raises the alert level on the coupled crisis of antimicrobial resistance (AMR) and a lack of antibiotic innovation. The GCOA-HGPI report, Taking Action for AMR Preparedness: Spurring Antibiotic Innovation for Healthy Ageing in Super-Ageing Japan, outlines the impact of AMR on older adults and the dire consequences for fiscal sustainability and economic growth for Japan and other aging societies while offering a roadmap for urgent action. The report is based on insights from a May roundtable hosted by the two organizations.

“AMR is at the top of serious global health threats,” said Michael W. Hodin, CEO, GCOA and moderator of the May roundtable. “It is finally becoming even more recognized as a critical priority as groups from the G7 to the WHO and OECD formally recognize and put forward calls to urgent action. As we noted at the roundtable, increasing drug resistance and the related crisis in antibiotic innovation are already claiming close to a million lives every year and projected to reach 10 million, shortly. Measures must be taken immediately,” Hodin said.

With far more old than young, and many in the population living to 100 years of age or more, super-aging Japan and other OECD countries are facing a stunning fiscal burden unless they can achieve healthy longevity. As agreed at the roundtable, AMR poses a particular threat to healthy aging, and with it, to fiscal sustainability.

“While AMR is a crisis for all society, older adults are at significant risk,” said Ryoji Noritake, CEO of HGPI and leader of the Japan AMR Alliance. “This fact makes access to novel antibiotics a crucial need for Japan, especially, where nearly 30% of our population is already today over 65, and 40% will be in the next years. If we want healthy longevity, we will need to focus on this AMR challenge even as we also support innovation for age-related NCDs,” said Noritake.

Based on the roundtable insights of Japanese and global experts in aging and infectious disease, the report lays out five key takeaways, offering a roadmap for action for Japan and other aging societies:

  1. Innovative policy structures that support antimicrobial innovation are being modeled in countries including the United Kingdom and the United States.
  2. AMR is an urgent issue for Japan in light of the impact that it is already having on Japan’s super-aging society.
  3. National action and global collaboration on AMR and antimicrobial innovation is essential. Countries must commit to AMR challenge themselves, though no single country can solve this problem by itself.
  4. There is a window of opportunity for Japan to recognize the important role of incentives for innovation in protecting the Japanese public from the impact of AMR.
  5. There are lessons learned from COVID-19 that could help to address the AMR crisis.

Click here to read the report in Japanese.

 

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.

Our National Conversation on Aging

Now that President Biden officially declared his run for a second term, what are we to make of the countless warnings about his age? Clearly, voters have already considered age a major factor – Google Search results for ‘Biden age’ hit an all-time-high just before the 2020 election – and speculation has only heightened four years on. Unfortunately, these concerns are misguided and even dangerous because they conflate age with poor health and confuse ideas about work and retirement.

World Immunization Week: Best-Kept Secret for 21st-Century Healthy Aging

The tremendous success of childhood immunisation campaigns across the 20thcentury is one of the greatest triumphs of public health. Along with advances in sanitation and antibiotics, childhood immunisation has resulted in the miracle of modern longevity: the once extravagant prospect of growing old has become the norm. Now, in our 21st century, isn’t it our great challenge to build on this achievement by realising a healthy longevity?

South China Morning Post Letter to the Editor

Antimicrobial resistance is one of the defining global problems of our time. Drug-resistant bacterial infections killed an estimated 1.27 million people in 2019. By 2050, 10 million lives annually could be lost to antimicrobial resistance, and annual global gross domestic product could fall by between 1.1 per cent and 3.8 per cent. Fortunately, Chinese policymakers, physicians and patients have shown what is possible when they focus collective efforts on antimicrobial resistance.

Medicine Price Setting Might Appeal to Voters but Will Cost Patients

As policymakers search for potential cuts to the national budget, they risk jeopardizing the country’s most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines , prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting this pipeline of medicine will not only improve health outcomes but will do so at a lower cost by reducing more expensive hospital and primary care.

Global Coalition on Aging Hosts Cross-Sector Roundtable to Tackle Heart Valve Disease in Aging Societies

The Global Coalition on Aging (GCOA) and the Global Heart Hub have released a global position paper “Heart Valve Disease: Harnessing Innovation to Save Lives, Mitigate Costs, and Advance the Healthy Aging Agenda.” The report builds upon on a December 2022 GCOA-GHH roundtable of cross-sector experts and examines how behavior and policy change can best address heart valve disease in our 21st century.

New York City Twins with Ireland to Develop Age Friendly Communities

The twinning commits both sides to share knowledge on age friendly programs and builds on the 2011 Dublin Declaration of Age-Friendly Cities and Communities. The agreement was signed by the Cathaoirleach (Mayor) Nick Killian of Meath County Council which hosts the Irish Age Friendly Programme and Lorraine Cortés-Vázquez, Commissioner for Aging.

Just Getting Started at 75

In the latest charge against the promise of healthy aging, Dr. Ezekiel Emanuel, oncologist and bioethicist, doubled down on his infamous 2014 essay stating that 75 is the ideal age to die. Now 65, he maintains that after age 75, he will no longer receive medical screenings and interventions like colonoscopies, cancer treatment, flu shots, and heart valve replacement.